Publications | CESAR l Center for Substance Abuse Research l University of Maryland

DEA Intelligence Report: Slang Terms and Code Words: A Reference for Law Enforcement Personnel (2018)Drug Enforcement Administration (DEA) dea-drug-slang-terms-and-code-words-july2018.pdf1.35 MB
DOTS Issue 5 - Uninsured Opioid Users Admitted to Medication-Assisted Treatment (MAT) Program in Palm Beach County, Florida, Found to Be Using Many Drugs in Addition to Opioids dots-bulletin-issue5-july2018-palmbeach-mat-final_0.pdf159.28 KB
DOTS Issue 6 - No Fentanyl Analogs but Buprenorphine, Naloxone, and Marijuana Detected in Specimens from Suspected Users of Fentanyl in Vermont dotsbulletin-issue6-july2018-aspenti-final_0.pdf121.62 KB
Drug Early Warning from Re-Testing Biological Samples: Maryland Hospital Study; Office of National Drug Control Policy. Washington, DC: Executive Office of the President. Wish, E.D., Billing, A.S., Artigiani, E.E., Dezman, Z., Schwartz, B., and Pueschel, J. (2018). FinalReport_CDEWS4_ED_Maryland-Hospital-Study.pdf2.62 MB
DEA Emerging Threat Report: Mid Year 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-mid-year.pdf426.96 KB
DEA Emerging Threat Report: Second Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-2.pdf361.4 KB
DOTS Issue 1 - Overview of the Drug Outbreak Testing Service Pilot Study dotsbulletin-issue1-june2018-methodology-final_0.pdf97.59 KB
DOTS Issue 2 - First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed dotsbulletin-issue2-june2018-baltimore-midtown-final_0.pdf160.4 KB
DOTS Issue 3 - Methamphetamine, Opioids, Cocaine, and Multiple Drugs Were Most Common in Specimens from Seattle/King County Area Decedents dotsbulletin-issue3-june2018-kingcomedicalex-final_0.pdf190.22 KB
DOTS Issue 4 - Drug-Positive Urine Specimens from Uninsured or Publicly Insured Residents of Montgomery County, Maryland, Contain No Fentanyl and Few Synthetic Cannabinoids but Do Contain Multiple Drugs dotsbulletin-issue4-june2018-accesstobh-final_0.pdf128.54 KB
First DOTS Study Finds Fentanyl and Polydrug Use in Patients Seen During Opioid Overdose Spike in Baltimore – Higher Doses of Naloxone May Be Needed; DOTS Bulletin Issue 2Zachary D.W. Dezman, MD, Assistant Professor, Department of Emergency Medicine, University of Maryland School of Medicine, Marwa F. Al-Nassir, BS; Amy S. Billing, MSSA; E. Erin Artigiani, MA; and Eric D. Wish, PhD, Center for Substance Abuse Research, Uni dotsbulletin-issue2-june2018-baltimore-midtown-final.pdf160.4 KB
DEA Emerging Threat Report: First Quarter 2018Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2018-quarter-1.pdf1.16 MB
Methamphetamine: A Regional Drug Crisis. College Park, MD: National Drug Early Warning System. (2018)Artigiani, E.E., Hsu, M.H., McCandlish, D., and Wish, E.D. ndews-scs-methamphetamine-report-september-2018-final.pdf1.16 MB
DEA Emerging Threat Report: Annual 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-annual.pdf1.47 MB
DEA Emerging Threat Report: Fourth Quarter 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-quarter-4.pdf1.28 MB
CDEWS News: CDEWS-3 Study Shows Changing Composition of Synthetic Cannabinoids in Washington, D.C. cdews-news_cdews3_dc_issue3_final_10.02.2017.pdf110.95 KB
DEA Emerging Threat Report: Third Quarter 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-quarter3.pdf1.91 MB
CDEWS News Inaugural Issue: Overview of the Community Drug Early Warning System Issue 1 | August 21, 2017 cdews-news-inaugural-issue1-final-8-21-2017.pdf86.79 KB
CDEWS News: Multiple Drugs Found in Maryland Probationers/Parolees Who Tested Positive for Opiates and/or FentanylIssue 2 | August 28, 2017 cdews-news-cdews3-maryland-issue2-final-8-28-2017.pdf85.45 KB
CDEWS Reports: Community Drug Early Warning System (CDEWS-3): Maryland -- Site 4 of 4; Office of National Drug Control Policy. Washington, DC: Executive Office of the President.Wish, E.D., Billing, A.S., and Artigiani, E.E. (2017). finalreport_cdews3_mdapproved.pdf625.42 KB
DEA Emerging Threat Report: Mid-Year 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-mid-year.pdf1.81 MB
DEA Emerging Threat Report: Second Quarter 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-quarter-2.pdf1.84 MB
CDEWS Report: Community Drug Early Warning System (CDEWS-3): Washington, DC – Site 3 of 4. Office of National Drug Control Policy. Washington, DC: Executive Office of the President.Billing, A.S., Artigiani, E.E., Robinson, J., Adatsi, F. and Wish, E.D. (2017). finalreport_cdews3_dc_v56_0.pdf660.51 KB
DEA Intelligence Report: Drug Slang Code Words (2017)Drug Enforcement Administration (DEA) dea-drug-slang-code-words-may2017.pdf2.85 MB
DEA Emerging Threat Report: First Quarter 2017Drug Enforcement Administration (DEA) Special Testing and Research Laboratory dea-emerging-threat-report-2017-quarter-1.pdf4.07 MB